Picture Not Available

Robert W. Mason, PhD

Contact Dr. Mason


,


Most Recent Peer-reviewed Publications

  1. Elevation of glycosaminoglycans in the amniotic fluid of a fetus with mucopolysaccharidosis VII
  2. Presentation and treatments for Mucopolysaccharidosis Type II (MPS II; Hunter Syndrome)
  3. Epidemiology of mucopolysaccharidoses
  4. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses
  5. Glycosaminoglycans detection methods: Applications of mass spectrometry
  6. Mucopolysaccharidosis IVA and glycosaminoglycans
  7. Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry
  8. Current therapies for Morquio A syndrome and their clinical outcomes
  9. Generation of pediatric leukemia xenograft models in NSG-B2m mice: Comparison with NOD/SCID mice
  10. Activity of daily living for Morquio A syndrome
  11. Cathepsin inhibition prevents autophagic protein turnover and downregulates insulin growth factor-1 receptor-mediated signaling in neuroblastoma
  12. Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma
  13. Disruption of Annexin II /p11 interaction suppresses leukemia cell binding, homing and engraftment, and sensitizes the leukemia cells to chemotherapy
  14. CD19-targeted nanodelivery of doxorubicin enhances therapeutic efficacy in B-cell acute lymphoblastic leukemia
  15. Loss of Sip1 leads to migration defects and retention of ectodermal markers during lens development
  16. Impact of enzyme replacement therapy and hematopoietic stem cell therapy on growth in patients with Hunter syndrome
  17. Novel heparan sulfate assay by using automated high-throughput mass spectrometry: Application to monitoring and screening for mucopolysaccharidoses
  18. Morquio A syndrome: Diagnosis and current and future therapies
  19. Newborn screening and diagnosis of mucopolysaccharidoses
  20. Dexamethasone-loaded block copolymer nanoparticles induce leukemia cell death and enhance therapeutic efficacy: A novel application in pediatric nanomedicine